---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-044886"
form_type: "8-K"
ticker: "IBRX"
cik: "0001326110"
company_name: "ImmunityBio, Inc."
filed_at: "2024-02-26T23:59:59+00:00"
generated_at: "2026-06-05T14:42:53.404111+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ImmunityBio awards $805K bonuses, 3.2M options, RSUs; sets 2024 exec pay

## Summary
- 2023 bonuses: Soon-Shiong $232,875, Adcock $298,500, Sachs $273,980; payable by March 15, 2024.
- Option grants: Soon-Shiong 1.19M NSOs, Adcock 1.59M ISOs, Sachs 424K ISOs at $5.24 strike.
- RSU grants: Soon-Shiong 342,987, Adcock 457,317, Sachs 121,951; vest ratably over 3 years.
- 2024 salary/target bonus: Soon-Shiong $621K/75%, Adcock $796K/75%, Sachs $575K/50%.

## SEC filing metadata
- accession: 0001193125-24-044886
- form_type: 8-K
- ticker: IBRX
- cik: 0001326110
- company_name: ImmunityBio, Inc.
- filed_at: 2024-02-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326110/000119312524044886/0001193125-24-044886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326110/000119312524044886/d785996d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-044886
- JSON: https://secwatch.observer/filing/0001193125-24-044886.json
- Plain text: https://secwatch.observer/filing/0001193125-24-044886.txt

## Key facts
- Governance Changes
  ImmunityBio, Inc.: Board approved a new Code of Business Conduct and Ethics, replacing the prior Code of Global Business Conduct and Ethics, with updated and enhanced provisions including policies on fair dealing and healthcare law compliance (effective 2024-02-22).
  - Change: code of ethics
  - Effective: 2024-02-22
  source text: On February 22, 2024, the Board of Directors (the “Board”) of the Company approved a Code of Business Conduct and Ethics to replace the Company’s prior Code of Global Business Conduct and Ethics (each acting as the Company’s “Code of Ethics”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326110/000119312524044886/0001193125-24-044886-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.